1. When is crossover desirable in cancer drug trials and when is it problematic?. (10th April 2018) Authors: Haslam, A; Prasad, V Journal: Annals of oncology Issue: Volume 29:Number 5(2018) Page Start: 1079 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗